Pre-Operative PARPi and Irradiation (POPI) in Women With an Incomplete Response to Neo-Adjuvant Chemotherapy for Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 19 Aug 2016
At a glance
- Drugs Veliparib (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 15 Aug 2016 Status changed from suspended to recruiting.
- 12 Nov 2015 Status changed from recruiting to suspended, as reported by ClinicalTrials.gov.
- 16 Aug 2013 Planned number of patients changed from 38 to 44 as reported by ClinicalTrials.gov.